Topical Imiquimod for Bowen's Disease of the Head and Neck

Summary

* Double blinded, randomized, placebo controlled trial of imiquimod for the treatment of histologically proven Bowens disease of the head and neck. * Null hypothesis: No difference in histologic clearance rates of patients with head or neck Bowens treated with imiquimod versus placebo. * Outcome: Histologic clearance of Bowens disease at T=14 weeks.

Timeline

Start

2006-11

Primary completion

2008-11

Completion

—

Drugs

Indications